Haifeng Wang
389 Xincun Road
Xincun, 200065, China
Xincun, 200065, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Rapid catalyst-free synthesis of α-selenomethyl ketones from sulfoxonium ylides and selenols.
Journal: Organic & biomolecular chemistry
Published: April 07, 2026
Label-free molecular profiling of cancer using Raman spectroscopy: from fundamentals to clinical applications.
Journal: Frontiers in oncology
Published: March 03, 2026
ASO Author Reflections: Risk Factors for Postoperative AE in Patients with Concomitant Lung Cancer and Idiopathic Pulmonary Fibrosis-Insights from Fibrosis Burden and Prophylactic Steroid Use.
Journal: Annals of surgical oncology
Published: December 23, 2025
Enantioselective Copper-Catalyzed N-H Insertion Reaction of Pyrazoles and α-Diazo Phosphates.
Journal: Organic letters
Published: November 10, 2025
Risk Factors for Postoperative Acute Exacerbations and Long-Term Survival in Patients with Concomitant Lung Cancer and Idiopathic Pulmonary Fibrosis.
Journal: Annals of surgical oncology
Published: July 18, 2025
Plant-recycling of waste tyre rubber into asphalt binder for sustainability: Insight into physicochemical behavior during terminal production.
Journal: PloS one
Published: July 17, 2025
The Role of Rho-associated Kinase in the Cognitive Benefits of the ACE Inhibitory Peptide LAP for Hypertension.
Journal: Current molecular medicine
Published: May 12, 2025
Validation and refinement of the ninth edition ypN descriptor in patients with non-small cell lung cancer receiving neoadjuvant therapy.
Journal: The Journal of thoracic and cardiovascular surgery
Published: April 15, 2025
The outcomes of neoadjuvant immunotherapy combined with antiangiogenic therapy versus chemoimmunotherapy in resectable non-small cell lung cancer: a propensity score matching analysis.
Journal: Journal of thoracic disease
Published: March 18, 2025
Neoadjuvant Immunochemotherapy for Stage II-IIIB Non-Small Cell Lung Cancer With Mutations Beyond EGFR 19del, L858R, and ALK Rearrangement.
Journal: The Annals of thoracic surgery
Published: December 30, 2024
ECM characterization and 3D bioprinted models of NSCLC for investigating stiffness-dependent tumor behavior and drug response.
Journal: Materials today. Bio
Published: December 29, 2024
Neoadjuvant camrelizumab plus chemotherapy or apatinib for resectable stage IIA-IIIA NSCLC: a multicenter, two-arm, phase II exploratory trial.
Journal: BMC medicine
Published: December 01, 2024
Last Updated: 09/26/2026